Top compounds associated with response to DYNLL2


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.2 0.0001
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.11 0.0001
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.19 0.0002
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.11 0.0002
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
Download CSV